Saturday, 10 October 2026European Markets

FASTNED Stock Is 9% Down So Far Today

Loading stream...

(VIANEWS) - Shares of FASTNED (AEX-Index: FAST.AS) slid 9.22% to €32.00 at 11:08 EST on Wednesday, after five sequential sessions in a row of losses. AEX-Index is dropping 1.39% to €755.36, following the last session's downward trend. This seems, at the moment, an all-around negative trend exchanging session today.

FASTNED's last close was €34.50, 25.65% under its 52-week high of €46.40.

About FASTNED

Fastned B.V., together with its subsidiaries, engages in the construction and operation of charging stations for fully electric cars. The company is also involved in the commercial operation of chargers at charging stations. It has operations in the Netherlands, Germany, the United Kingdom, Belgium, France, Switzerland, and Italy. The company was incorporated in 2012 and is based in Amsterdam, the Netherlands. Fastned B.V. is a subsidiary of Fastned Administratie Stichting.

Earnings Per Share

As for profitability, FASTNED has a trailing twelve months EPS of €-1.26.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -16.46%.

More news about FASTNED (FAST.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com